Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2025-12-26 @ 11:17 AM
Study NCT ID:
NCT03591666
Status:
UNKNOWN
Last Update Posted:
2018-07-19
First Post:
2018-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas
Sponsor:
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-07-09
First Submit QC Date:
None
Study First Post Date:
2018-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-09
Last Update Post Date:
2018-07-19
Last Update Post Date Type:
ACTUAL